Opportunity Information: Apply for PCLM 2025
The PEPFAR Community Led Monitoring (CLM) - Zambia funding opportunity is a U.S. Mission to Zambia (U.S. Embassy Zambia) cooperative agreement designed to strengthen the quality of HIV services by systematically collecting and using feedback from people receiving PEPFAR-supported HIV care. The core idea is that trained community members gather client experiences directly from health facility users, then that information is triangulated, summarized, and shared with key decision-makers so gaps in service delivery can be identified and fixed. PEPFAR Zambia and Zambia's Ministry of Health (MOH), working alongside bodies like the National HIV/AIDS, STI, and TB Council (NAC), use the findings to improve the client experience and ultimately strengthen HIV outcomes across the country.
This program builds on CLM work that began in 2021, when PEPFAR supported not-for-profit organizations to implement monitoring activities in each province. Starting around May 2025, PEPFAR intends to continue CLM in a way that strengthens prior efforts and places stronger emphasis on systematically addressing the feedback that communities provide. A key feature of the approach is holding quarterly review meetings with government and other stakeholders to discuss recurring problems and barriers to service uptake at site and facility level. PEPFAR is specifically looking for community-based applicants in every province, with encouragement to integrate PLHIV-focused community organizations as the local structures that help reach clients and support sustained engagement.
The grant expects implementers to run feedback collection in two phases: phase one establishes a baseline picture of service quality and client experience, and phase two measures change over time to show whether service delivery improved after issues were raised and addressed. Grantees are expected to cover both low- and high-volume facilities, and to ensure feedback reflects rural and urban realities. The monitoring must be inclusive and representative, explicitly covering all constituencies of people living with HIV (PLHIV), including but not limited to key populations (KP), adolescent girls and young women (AGYW), persons with disabilities, pregnant and breastfeeding women (PBFW), and also pediatrics as referenced in the proposal instructions. The NOFO is clear that applications without a credible plan to include all constituencies will not be considered, making inclusivity a non-negotiable requirement rather than a general preference.
In terms of required outputs and ongoing responsibilities, grantees must collect client feedback across their province using a harmonized reporting tool developed by stakeholders, and they must synthesize and share that feedback with stakeholders subject to PEPFAR and MOH approval. Routine reporting is central to the award: monthly programmatic reporting is required, alongside quarterly summarized program indicators and quarterly financial reporting. Programs must also track and document changes between phase one and phase two, participate in quarterly coordination meetings with government, community representatives, USG, and implementing partners, and produce actionable recommendations that can realistically improve client care based on what recipients of care report. The program places emphasis on supportive supervision and quality assurance of field teams so that collection is done correctly and reports are submitted on time throughout the award period.
Eligible applicants are not-for-profit entities, including civil society organizations, NGOs, and public or private educational institutions. PEPFAR is seeking applicants that can demonstrate capacity to collaborate with PEPFAR, MOH, NAC, and other stakeholders, as well as the ability to manage a province-wide community monitoring program. The proposal instructions also ask applicants to describe organizational experience and past operations, including prior management of funding programs of at least USD 25,000 and any previous U.S. government grants, which signals that applicants should be able to demonstrate at least some baseline grants management and compliance capability. If an applicant plans to sub-award, they must explain how sub-awardees will be managed, how reporting will be tracked, and how compliance will be maintained, and they must also provide assurance they are not operating under a competing interest for this program.
On the funding and award structure, this opportunity is listed as a discretionary cooperative agreement under CFDA 19.029. The posted award ceiling is USD 115,000, with an anticipated 10 awards. Applicants are instructed to prepare budgets in U.S. dollars and to calculate using an exchange rate of USD 1 = ZMW 25 (as of July 2024). Because this is a cooperative agreement, applicants should expect meaningful ongoing involvement from PEPFAR Zambia in oversight and coordination, especially around how feedback is synthesized, validated, and shared with stakeholders, even though the grantees lead on collection and reporting.
Applications must be submitted electronically through Grants.gov only, and paper or email submissions will not be accepted. The deadline is February 17, 2025 by midnight Zambia time. Required submission components include standard federal forms (SF-424, SF-424A, SF-424B), a summary cover sheet that names the organization and the province applied for, a detailed proposal that explains methodology and monitoring plans in plain terms, key personnel details (including roles and level of effort), partner/sub-awardee information, and a budget justification provided as both a detailed budget and a narrative. Attachments must include CVs/resumes of key personnel, letters of support from partners (if applicable), and three reference letters, including one from an international organization with annual funding of USD 25,000 or more. Applicants requesting more than USD 100,000 must also submit SF-LLL (Disclosure of Lobbying Activities). Questions must be submitted by email to the PEPFAR Zambia Grants Team (lusakasmallgrants@state.gov) by January 20, 2025, with responses expected to be posted by February 3, 2025 on the PEPFAR Zambia webpage.Apply for PCLM 2025
- The U.S. Mission to Zambia in the health sector is offering a public funding opportunity titled "PEPFAR Community Led Monitoring (CLM)-Zambia" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 19.029.
- This funding opportunity was created on 2024-12-09.
- Applicants must submit their applications by 2025-02-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $115,000.00 in funding.
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Sustainable Skills for Sustainable Communities – An Education Skills Program in support of the sustainable economic diversification of vulnerable communities in Mpumalanga, South Africa.
Previous opportunity: Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PCLM 2025
Applicants also applied for:
Applicants who have applied for this opportunity (PCLM 2025) also looked into and applied for these:
| Funding Opportunity |
|---|
| USAID SUstaining Control of the HIV Epidemic through quality Services, resilient Systems, and Community Outreach (SUCESSO) _ Sofala & Niassa Apply for 72065625RFA00002 Funding Number: 72065625RFA00002 Agency: Mozambique USAID-Maputo Category: Health Funding Amount: $77,500,000 |
| NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) Apply for PAR 25 251 Funding Number: PAR 25 251 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| USAID Sustaining Control of the HIV Epidemic through quality Services, resilient systems, and Community Outreach (SUCESSO) - Tete & Manica Apply for 72065625RFA00005 Funding Number: 72065625RFA00005 Agency: Mozambique USAID-Maputo Category: Health Funding Amount: $77,500,000 |
| Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional) Apply for PAR 25 310 Funding Number: PAR 25 310 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) Apply for PAR 25 297 Funding Number: PAR 25 297 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) Apply for PAR 25 026 Funding Number: PAR 25 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) Apply for PAR 25 025 Funding Number: PAR 25 025 Agency: National Institutes of Health Category: Health Funding Amount: $1,515,000 |
| High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional) Apply for RFA OD 25 001 Funding Number: RFA OD 25 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) Apply for PAR 25 239 Funding Number: PAR 25 239 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 Independent Clinical Trial Not Allowed) Apply for PAR 24 286 Funding Number: PAR 24 286 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) Apply for RFA TR 25 002 Funding Number: RFA TR 25 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) Apply for PAR 25 230 Funding Number: PAR 25 230 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) Apply for PAR 24 289 Funding Number: PAR 24 289 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Coordination Center for the Alzheimers Disease Sequencing Project Consortium (U01 Clinical Trial Not Allowed) Apply for RFA AG 25 015 Funding Number: RFA AG 25 015 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) Apply for PAR 24 287 Funding Number: PAR 24 287 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) Apply for PAR 24 280 Funding Number: PAR 24 280 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Apply for PAR 25 141 Funding Number: PAR 25 141 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional) Apply for RFA MD 24 011 Funding Number: RFA MD 24 011 Agency: National Institutes of Health Category: Health Funding Amount: $3,500,000 |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) Apply for PAR 24 279 Funding Number: PAR 24 279 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed) Apply for PAR 25 045 Funding Number: PAR 25 045 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PCLM 2025", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
